In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

FDA Sets Date for Advisory Committee Meeting for Midomafetamine for PTSD ...

During the COVID-19 pandemic, healthcare workers faced several mental health challenges, experiencing repeated exposure to ...

An intervention program that coaches patients in stress management and goal setting, along with a digital app, helped ...

Gene therapies have a lot of potential to improve health outcomes for patients with life-threatening diseases but face a ...

Lindsay Bealor Greenleaf, JD, MBA; Ryann Hill, MPH; Patrick Cooney ...

After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked ...

The campaign for hand eczema is the latest in a number of high-cost campaigns to raise awareness of dermatological conditions ...

Short-term hormone therapy lasting four years initiated within three years of the last menstrual cycle had no long-term ...

President-elect Donald Trump announced last Thursday, Nov. 14, that Kennedy, 70, was his pick to head the Department of ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The FDA has approved UCB's Bimzelx for moderate-to-severe hidradenitis suppurativa, offering a new treatment option for this ...